The Impakt webcast is supported by
an unrestricted educational grant by sanofi aventis
1. Molecular grading in breast cancer: a new perspective on tumor grading and its impact on treatment decision
(2009-05-07, 12:15:00 - 13:30:00)
TUMOR GRADING: HISTOLOGICAL ASSESSMENT AND ITS USE IN PROGNOSTICATION INDEXES
(A. Lee)
TUMOR GRADING: THE CONTRIBUTION OF MOLECULAR APPROACHES
(C. Sotiriou)
USE OF MOLECULAR SIGNATURES TO PREDICT TREATMENT RESPONSE
(C. Liedtke)
INTEGRATING MOLECULAR TOOLS INTO CLINICAL PRACTICE: THE PERSPECTIVE OF A REFERENCE CENTRE
(F. Andre)
2. Official Welcome
(2009-05-07, 13:45:00 - 14:00:00)
Welcome Talk
(J. Baselga, M. Piccart)
3. Keynote Lecture
(2009-05-07, 15:00:00 - 15:30:00)
DESIGNING CLINICAL TRIALS TO GUIDE TREATMENT FOR INDIVIDUAL PATIENTS
(R. D. Gelber)
4. Keynote Lectures: Overcoming endocrine resistance with signal transduction inhibitors: are we failing?
(2009-05-07, 15:30:00 - 16:30:00)
GROWTH FACTOR SIGNALLING COMPLEXITY INDUCED BY ANTI-HORMONES AND ANTI-GROWTH FACTORS: A POSSIBLE MEANS OF ABROGATING RESPONSE AND PROMOTING CANCER PROGRESSION
(R. Nicholson )
BACK TO BASICS: OESTROGEN TO KILL ANTI-HORMONE RESISTANT BREAST CANCER
(V. Jordan)
5. Creativity in the development of drug response biomarkers
(2009-05-07, 17:00:00 - 18:30:00)
BIOMARKER OPPORTUNITIES: TURNING THEORY INTO PRACTICE
(P. S. Huang)
FUNCTIONAL GENETIC APPROACHES TO IDENTIFY DRUG RESPONSE BIOMARKERS
(R. Bernards)
NOVEL PARADIGMS FOR PERSONALIZED THERAPY AND DRUG DISCOVERY IN CANCER
(D. Theodorescu)
6. Keynote Lecture
(2009-05-08, 08:00:00 - 08:30:00)
CANCER AS A DISEASE OF SEEDING RATHER THAN MITOSIS: IMPLICATION FOR RECEPTOR TARGETING
(L. Norton)
7. The biomarkers forum: handling the multifaceted essence of cancer. Tumors and nodes biomarkers
(2009-05-08, 08:30:00 - 10:10:00)
MULTIPLEXED ASSESSMENT OF PROTEIN EXPRESSION IN TISSUE BIOPSIES
(D. L. Rimm)
GENE EXPRESSION PROFILING
(C. Sotiriou)
MOLECULAR DIAGNOSES OF LYMPH NODE METASTASES
(R. Mansel)
TRANSCRIPTIONAL REGULATION OF ERBB2 BY ESTROGEN RECEPTOR-PAX2 DETERMINES RESPONSE TO TAMOXIFEN
(A. Hurtado)
8. Poster presentation
(2009-05-08, 10:10:00 - 10:40:00)
9. The biomarkers forum: handling the multifaceted essence of cancer. Blood and host biomarkers
(2009-05-08, 10:40:00 - 12:00:00)
CIRCULATING TUMOR CELLS
(M. Ignatiadis)
PHARMACOGENETICS
(R. Danesi)
PROTEOMIC STRATEGIES IN BREAST CANCER RESEARCH
(J. Celis)
10. Poster discussion session
(2009-05-08, 12:30:00 - 13:30:00)
DISCUSSANT, ABSTRACTS 41PD AND 94PD
(J. E. Garber, J. E. Garber)
DISCUSSANT, ABSTRACTS 42PD AND 60PD
(A. Di Leo)
DISCUSSANT, ABSTRACT 128PD
(M. Dowsett)
11. Functional imaging of the breast and adjacent nodes: light from the darkness?
(2009-05-08, 13:45:00 - 14:45:00)
FUNCTIONAL MRI TECHNIQUES FOR ASSESSING BREAST CANCER TREATMENT RESPONSE
(N. Hylton)
12. Local treatment: hit the target and spare the normal tissue
(2009-05-08, 15:15:00 - 16:30:00)
SENTINEL NODE WHEN, FOR WHOM AND HOW
(T. Kühn)
INNOVATIVE SURGICAL APPROACHES
(R. Rouzier)
RESEARCH ADVANCES IN RADIATION TREATMENTS FOR BREAST CANCER
(T. Buchholz)
PREDICTION OF AXILLARY STATUS FROM SENTINEL LYMPH NODE TESTING WITH AN INTRA-OPERATIVE RT-PCR TEST – MULTI-CENTER ANALYSIS OF 1138 PATIENTS
(D. Larsimont)
13. Teaching an old dog new tricks
(2009-05-08, 16:30:00 - 17:45:00)
TAMOXIFEN: TEACHING AN OLD DOG NEW TRICKS
(I. Smith )
TEACHING AN OLD DOG NEW TRICKS: ALKYLATING AGENTS
(J. E. Garber)
CAN WE USE ANTHRACYCLINES (A) AS TARGETED AGENTS?
(A. Di Leo)
ANDROGEN-RECEPTOR EXPRESSION IN TRIPLE NEGATIVE BREAST CANCER: RESULTS FROM THE NEOADJUVANT GEPARTRIO TRIAL
(S. Loibl)
14. Keynote lecture
(2009-05-09, 08:00:00 - 08:30:00)
BREAST CANCER PROGRESSION: DID WE GET IT WRONG?
(C. A. Klein)
15. Is dormancy targetable?
(2009-05-09, 08:30:00 - 09:15:00)
THERAPEUTIC TARGETING OF TUMOR CELL DIVERSITY
(K. Polyak)
IS DORMANCY TARGETABLE? THE CLINICIAN: A POINT OF VIEW
(J. Baselga)
DISCUSSION
(A. Goldhirsch)
16. Pathways for PI3Kinase
(2009-05-09, 09:15:00 - 10:00:00)
PATHWAYS FOR PI3KINASE. THE CLINICIAN: A POINT OF VIEW
(N. Rosen)
DISCUSSION
(J. Baselga)
17. Angiogenesis
(2009-05-09, 10:15:00 - 11:30:00)
GENETICS IN ANGIOGENESIS AND ITS INFLUENCE ON CLINICAL DECISION MAKING
(D. Lambrechts)
ANGIOGENESIS. THE CLINICIAN: A POINT OF VIEW
(J. Bergh)
DISCUSSION
(D. Cameron, D. Cameron)
18. Furthering the fight against breast cancer: Susan G. Komen for Cure’s commitment to research
(2009-05-09, 11:30:00 - 12:00:00)
FURTHERING THE FIGHT AGAINST BREAST CANCER: SUSAN G. KOMEN FOR CURE’S COMMITMENT TO RESEARCH
(N. Brinker, N. Brinker)
19. Growth factor receptors targeting
(2009-05-09, 12:00:00 - 13:00:00)
GROWTH FACTOR RECEPTORS TARGETING. THE CLINICIAN: A POINT OF VIEW
(S. R. Johnston)
GROWTH FACTOR RECEPTORS TARGETING. IMAGING
(E. De Vries)
DISCUSSION
(F. Andre)
 

© 2009, EMCTO
To display the content of the website correctly you need Flash Player 8 for Windows or Flash Player 7 for MacOS. Download the newest version and install it, this requires only a few minutes.